Profound Medical (NASDAQ:PROF – Get Free Report) will announce its earnings results after the market closes on Thursday, May 9th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter.
Profound Medical (NASDAQ:PROF – Get Free Report) last announced its earnings results on Thursday, March 7th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.28) by ($0.14). Profound Medical had a negative return on equity of 70.18% and a negative net margin of 396.85%. The company had revenue of $2.01 million for the quarter, compared to analyst estimates of $1.90 million. On average, analysts expect Profound Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Profound Medical Stock Up 0.7 %
Shares of NASDAQ PROF opened at $7.42 on Tuesday. The company’s 50 day simple moving average is $8.20 and its 200 day simple moving average is $8.69. Profound Medical has a fifty-two week low of $7.11 and a fifty-two week high of $15.49. The company has a debt-to-equity ratio of 0.16, a quick ratio of 5.48 and a current ratio of 6.58.
Profound Medical Company Profile
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.
See Also
- Five stocks we like better than Profound Medical
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- 3 Healthcare Dividend Stocks to Buy
- 3 Value Stocks You Can Buy Before They Become Big
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Profound Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Profound Medical and related companies with MarketBeat.com's FREE daily email newsletter.